VXK Products LLC producing VESTEX protected fabrics, apparel, and other products, has been granted a patent bearing no. 11,206,886 by the US Patent & Trademark Office (USPTO) for “Fluid-Repellant, Antimicrobial Fabrics, and Methods of Making Same”.
The patent codified the application processes to create VESTEX’s dual mechanism of fabrics approved by the U.S Food & Drug Administration (FDA) 510(k) for microbial and body fluid protectiveness on the outside and breathable wicking ability on the inside facing the skin for comfort.
Chief Executive Officer of Vestagen Technologies, Ben Favret, believes that the patent will help the company assign the patented process to licensed manufacturing partners to create a variety of new products with VESTEX’s dual mechanism fabrics to better protect wearers in healthcare, frontline services, and food service/manufacturing.
Ben believes that the patent will also positively impact the way current and potential licensed manufacturers and wearers perceived VESTEX clothing. “The term ‘patented’ validates that VESTEX offers them something that no one else can: credible protection and comfort for wearers and brands.” In addition, it also protects licensee and certified application partners, not to mention VESTEX protected product buyers, from inferior products that do not meet the effectiveness, safety, and comfort requirements, Favret added. “It helps us deter knock-offs and separates us from lesser performing, also-ran products in the space.”
Besides VESTEX’s effectiveness in reducing over 99.99% of MSRA organisms and repelling blood, urine, sputum, gastric fluid, and bleach to protect wearers that earned FDA’s clearance, it has also proven to reduce human coronavirus on VESTEX-treated clothing and testing using commonly available model human Coronaviruses. As a result of this, the company has also applied for clearance from FDA on the fabric’s effectiveness against human coronaviruses.
Chief Technology Officer and lead author of the patent, Darwin Clarke, said “The patent further validates the uniqueness of our VESTEX formulation, application, and effectiveness,”
“It builds upon our intellectual property protection strategy that includes our 510(k) clearance as a Class II medical device which defines a new FDA product code, Trade Secrets, EPA registration, selection as a Newsweek Best Infection Prevention product, recommendation by National Science Foundation and previous endorsement by the American Hospital Association. All of which are rooted in the extensive published research documenting the unparalleled effectiveness and safety of VESTEX protected products.”
“With this gold standard of IP protection, VESTEX has secured the position as market leader in this space,” Favret stated.
He went on to add that this patent is just the beginning of more innovation and also enable collaboration with other companies that are keen on catering to the rising public demand for protective clothing by applying for manufacturing license or directly selling VESTEX products.
Important facts about VESTEX®
1. VESTEX apparel uses antimicrobial and fluid repellent technologies for added protection and comfort to wearers working who are at risk of exposure to disease-causing microorganisms from blood, body fluids, and other infectious substances.
2. VESTEX apparel is designed to replace non-protective clothing and work in conjunction with PPE that is work for specific reasons and for a given period of time where the wearer may possibly come in contact with infectious pathogens and body fluids.
3. VESTEX healthcare clothing was the first daily-wear scrubs to receive a Class II medical device designation from the FDA.
4. VESTEX remains the defining product in the new FDA product category created for protective medical device apparel.
5. VESTEX was the first proven fabric in a hospital setting with reduced acquisition and retention of microbes in everyday use Bearman et al.
6. VESTEX is endorsed by the American Hospital Association and recommended by the National Science Foundation Center for Healthcare Transformation.
About VESTEX: VESTEX®, is the first a new class of FDA 510(k)Cleared Active Barrier protective apparel combining antimicrobial, fluid repellent and comfort properties. The Association of Professionals in Infection Control (APIC) likens clothing to “a virtual conveyer belt for infection.” VESTEX fabric is designed to protect uniforms and work apparel by reducing the acquisition, retention and transmission of microorganisms on clothing. Based on the research reviewed by the FDA, VESTEX earned an exclusive endorsement from the American Hospital Association (AHA) in 2015 following the proprietary AHA Signature Due Diligence Process. Recent studies concluded VESTEX is more effective than conventional uniforms at repelling fluids and reducing the retention of methicillin-resistant staph on the fabric. For more information, or to inquire about partnerships and licensing opportunities, visit the newly relaunched and totally redesigned website, VESTEX.com.
Recommended Reads: Use Of Antimicrobial Finishing On Polyester Fabric In Modern Day Textiles
 for “Fluid-Repellant, Antimicrobial Fabrics, and Methods of Making Same”. ){kind=link}